← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN ESTOLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LIFE LABS · Approved 1982-12-17

Drug application

FDA Application #

ANDA062362

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN ESTOLATE

Generic name

Erythromycin Estolate

Active ingredients

ERYTHROMYCIN ESTOLATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

LIFE LABS

First approval

1982-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown